These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6220094)

  • 1. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Pier GB; Matthews WJ; Eardley DD
    J Infect Dis; 1983 Mar; 147(3):494-503. PubMed ID: 6220094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.
    Ramphal R; Pier GB
    Infect Immun; 1985 Jan; 47(1):1-4. PubMed ID: 3155514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
    Pier GB; Elcock ME
    J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharide antigens of Pseudomonas aeruginosa.
    Pier GB
    Rev Infect Dis; 1988; 10 Suppl 2():S337-40. PubMed ID: 3142017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
    Pier GB; DesJardin D; Grout M; Garner C; Bennett SE; Pekoe G; Fuller SA; Thornton MO; Harkonen WS; Miller HC
    Infect Immun; 1994 Sep; 62(9):3972-9. PubMed ID: 8063415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Stiver HG; Zachidniak K; Speert DP
    Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria.
    König B; Friedl P; Pedersen SS; König W
    Int Arch Allergy Immunol; 1992; 99(1):98-106. PubMed ID: 1336422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nutrient media on the characteristics of the exopolysaccharide produced by three mucoid Pseudomonas aeruginosa strains.
    Buckmire FL
    Microbios; 1984; 41(163):49-63. PubMed ID: 6441885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis.
    Daley L; Pier GB; Liporace JD; Eardley DD
    J Immunol; 1985 May; 134(5):3089-93. PubMed ID: 3920310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
    Ames P; DesJardins D; Pier GB
    Infect Immun; 1985 Aug; 49(2):281-5. PubMed ID: 3160660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa.
    Bayer AS; Eftekhar F; Tu J; Nast CC; Speert DP
    Infect Immun; 1990 May; 58(5):1344-9. PubMed ID: 2139011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.
    Kashef N; Behzadian-Nejad Q; Najar-Peerayeh S; Mousavi-Hosseini K; Moazzeni M; Djavid GE
    J Med Microbiol; 2006 Oct; 55(Pt 10):1441-1446. PubMed ID: 17005795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Shand GH
    J Clin Microbiol; 1989 Apr; 27(4):691-9. PubMed ID: 2498389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
    Doggett RG; Harrison GM
    Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.